A 2025 Westgard QC survey finds daily out-of-control quality control events reported by 33% of labs worldwide and 45% in the US, raising concerns about current QC practices amid rising operational pressures.
Read More
MolDX has proposed a draft Local Coverage Determination to establish Medicare coverage criteria for optical genome mapping in hematologic neoplasms, with public comment open through Oct. 11, 2026, according to Bionano Laboratories.
Read More
PixCell Medical has received Health Canada Class III licensing for its HemoScreen point-of-care hematology analyzer and signed a Canadian distribution agreement with Inter Medico, expanding access to decentralized CBC testing.
Read More
From clot formation to functional and antigen testing, fibrinogen measurement helps laboratories evaluate bleeding disorders, monitor critical illness, and support patient care.
Read More
Hematogenix’s next-generation flow cytometry assay was used as the pivotal efficacy measure supporting FDA accelerated approval of ZENBEXUS, the first CELMoD therapy for multiple myeloma.
Read More